Viewing Study NCT00181558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-02-20 @ 1:33 PM
Study NCT ID: NCT00181558
Status: COMPLETED
Last Update Posted: 2010-05-10
First Post: 2005-09-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
Sponsor: Massachusetts General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Adenocarcinoma of the Prostate View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Cancer View
None bone metastases View
None Atrasentan View
None Zometa View
None Androgen Independent Prostate Cancer View